Cargando…
Detecting Waning Serological Response with Commercial Immunoassays: 18-Month Longitudinal Follow-up of Anti-SARS-CoV-2 Nucleocapsid Antibodies
Past severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is an important determinant of protection from reinfection and of postvaccine immune responses. Herein, we conducted a follow-up analysis of health care workers previously infected with coronavirus disease 2019 (COVID-19) wi...
Autores principales: | Nakagama, Yu, Komase, Yuko, Kaku, Natsuko, Nitahara, Yuko, Tshibangu-Kabamba, Evariste, Tominaga, Tomoyo, Tanaka, Hiroko, Yokoya, Tomoaki, Hosokawa, Minako, Kido, Yasutoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430644/ https://www.ncbi.nlm.nih.gov/pubmed/35867423 http://dx.doi.org/10.1128/spectrum.00986-22 |
Ejemplares similares
-
A Dual-Antigen SARS-CoV-2 Serological Assay Reflects Antibody Avidity
por: Nakagama, Yu, et al.
Publicado: (2022) -
Age-adjusted impact of prior COVID-19 on SARS-CoV-2 mRNA vaccine response
por: Nakagama, Sachie, et al.
Publicado: (2023) -
Serological Testing Reveals the Hidden COVID-19 Burden among Health Care Workers Experiencing a SARS-CoV-2 Nosocomial Outbreak
por: Nakagama, Yu, et al.
Publicado: (2021) -
High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients
por: Nitahara, Yuko, et al.
Publicado: (2021) -
Cumulative seroprevalence among healthcare workers after the first wave of the COVID-19 pandemic in El Salvador, Central America
por: Nakagama, Yu, et al.
Publicado: (2022)